CIBC Maintains Neutral on Ovintiv, Raises Price Target to $75

Benzinga Newsdesk www.benzinga.com Positive 60.8%

Neg 0% Neu 0% Pos 60.8%

CIBC analyst Dennis Fong maintains Ovintiv (NYSE:OVV) with a Neutral and raises the price target from $65 to $75.

Comments

No comments yet. Be the first!